Aspirin/Carisoprodol

阿司匹林/卡立普多

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Carisoprodol
Drug Alias NameCarisoprodol and Aspirin卡立普多阿司匹林Acetylsalicylic acid/Carisoprodol阿司匹林卡立普多卡立普多/乙酰水杨酸 +[12] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsMusculoskeletal Pain
Global Approved IndicationsMusculoskeletal Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1960/09/12
Country/TerritoryUnited States
CombinationsYes CarisoprodolAspirin
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeda Ab
Active IndicationsN/A
Inactive IndicationsMusculoskeletal Pain

Other Information

ATC CodeN/A
Related LinksN/A